Search Results

November 2021 Addex's strategic partner The Janssen Pharmaceutical Companies of Johnson & Johnson, Inc today announced that Janssen Pharmaceuticals, Inc., part of the Janssen Pharmaceutical Companies of Johnson & Johnson, has successfully completed Phase 1 studies in Japan with JNJ-40411813 (ADX71149).

June 2022 "Published on juin 22, 2022 On June 22, 2022, Michel Bouvier, Chief Executive Officer of IRIC

year, Novo Nordisk is strengthening its position in the obesity space through a collaboration with EraCal Under the joint research plan, the Danish giant will work with EraCal to identify novel drug targets Although specific details of the collaboration are yet to be released, EraCal has confirmed that the

: Virion Display to Discover a Novel Ligand of the Orphan GPCR GPRC5B and its Role in Obesity About Eric Johansen "I will be a 6th year Ph.D student in the chemical biology interface program at Johns Hopkins Eric Johansen on the web Johns Hopkins University Dr.

Kari Johnson About this episode Dr. Kari Johnson is currently an assistant professor at the Uniformed Services University of the Health Sciences Kari Johnson on the web LinkedIn Google Scholar Research Gate USU Twitter Dr.

over 20 years of experience in the medtech and diagnostics industries, having held senior roles at Johnson & Johnson and Danaher across the EMEA region in sales, marketing, and general management.